Portal de Periódicos da CAPES

HIV-2 Drug Resistance Genotyping from Dried Blood Spots

2020; American Society for Microbiology; Volume: 59; Issue: 1 Linguagem: Inglês

10.1128/jcm.02303-20

1098-660X

Dana N. Raugi, Robert S. Nixon, Sally Leong, Khadim Faye, Jean Phillipe Diatta, Fatima Sall, Robert A. Smith, ElHadji Ibrahima Sall, Jean Jacques Malomar, Moussa Seydi, Geoffrey S. Gottlieb,

HIV/AIDS Research and Interventions

The treatment of HIV-2 in resource-limited settings (RLS) is complicated by the limited availability of HIV-2-active antiretroviral drugs and inadequate access to HIV-2 viral load and drug resistance testing. Dried blood spots (DBS)-based drug resistance testing, widely studied for HIV-1, has not been reported for HIV-2 and could present an opportunity to improve care for HIV-2-infected individuals. We selected 150 DBS specimens from ongoing studies of antiretroviral therapy (ART) for HIV-2 infection in Senegal and subjected them to genotypic drug resistance testing.